Policy Change

Regulatory tailwinds and a user-first feature set are fueling Opera's surge in Western markets, revealing cracks in the long-held browser monopoly.

A new watchdog emerges as millions use unapproved GLP-1 drugs, many believing they're FDA-approved. How a shortage solution became a risky shadow market.

A new medical report confirms artificial stone dust causes a fatal, fast-acting lung disease, finding safety controls inadequate and sparking calls for a ban.

A rare mid-year IRS mileage rate hike to 76 cents isn't just about gas prices. It's a signal of persistent volatility forcing a strategic rethink.

Mayor Mamdani defends NYC's closed primaries, sparking a showdown with advocates who say the system disenfranchises over a million New Yorkers.

The EPA wants to change how diesel emissions are enforced, but trucking and fuel groups warn the move could disrupt a key environmental success story.

Vermont's decision to grant CRNAs autonomy isn't just policy; it's a test case for solving rural healthcare gaps and a flashpoint in the future of work.

The 2026 stroke care overhaul is more than a medical update; it's a market shockwave forcing hospitals into a multi-billion dollar tech race. Who wins?

A historic bipartisan bill to fight organized cargo crime lands in the Senate as industry leaders warn of a crisis costing the U.S. economy up to $35 billion.

A proposed Medicare payment rule puts Neuspera Medical’s innovative sacral neuromodulation device on par with industry giants, signaling a major shift.

As British Columbia fast-tracks major fossil fuel projects for economic security, First Nations leaders warn that constitutional rights are being sidelined.

As federal deadlines for quantum-proof security loom, a retired Navy admiral joins a tech firm. This isn't just a new job; it's a national security race.

Keiko Fujimori's narrow victory in Peru signals a major policy shift, potentially fast-tracking key lithium and uranium projects for the global tech supply chain.

As parts of Quebec face renewed fire bans, we explore the adaptive system of prevention, the heavy weight of public responsibility, and the paradox of a successful yet stressful fire season.

The DEA's move to schedule synthetic 7-OH creates a new regulatory moat. For companies like VIVAZEN, it’s a strategic bet on transparency. For the industry, it’s a forced maturation.

A final SBA loan extension for LA wildfire survivors isn't a solution, but a symptom of a recovery paralyzed by red tape and a broken insurance market.

Effective today, Charlie's Law mandates new anti-bullying protections in Virginia's private schools, a change driven by a family's tragedy and advocacy.

Millions of older Americans can now access the popular weight-loss drug Wegovy for a $50 copay, a temporary move that could reshape healthcare policy and the pharma market.

Seven years in, the CROWN Act has changed laws in 30 states. But as Dove's new campaign shows, the battle against hair discrimination is far from over.

With a new federal tax credit on the horizon, Legacy Deo is launching a scholarship organization to reshape funding for Christian education across Texas.